Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.22 EUR | +0.10% | +0.29% | +34.54% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 03 | AIB GROUP : Stronger revenue growth and a benign cost of risk |
Evolution of the average Target Price on AIB Group plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering AIB Group plc
alphavalue | David Grinsztajn |
Goldman Sachs | |
Berenberg Bank |
EPS Revisions
- Stock Market
- Equities
- A5G Stock
- Consensus AIB Group plc